NCT07194070View on ClinicalTrials.gov

A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

RecruitingOBSERVATIONAL
Enrollment

175

Participants

Timeline

Start Date

November 28, 2025

Primary Completion Date

May 26, 2030

Study Completion Date

September 30, 2030

Conditions
Hemolytic Disease of the Fetus and Newborn
Interventions
OTHER

Standard of Care

No study treatment will be administered as part of this study. Participants will receive standard of care therapy as per local clinical practice.

Trial Locations (3)

45219

RECRUITING

University of Cincinnati, Cincinnati

77030

RECRUITING

Baylor College of Medicine, Houston

00137

RECRUITING

Fondazione Policlinico Universitario A Gemelli IRCCS, Roma

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY